Cargando…
SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma
BACKGROUND: Glioma is a fatal tumor originating from the brain, which accounts for most intracranial malignancies. Currently, Immunotherapy has turned into a novel and promising treatment in glioma patients. however, there are still few effective biomarkers to mirror the reaction to immunotherapy in...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748290/ https://www.ncbi.nlm.nih.gov/pubmed/36531992 http://dx.doi.org/10.3389/fimmu.2022.980378 |